by Eric Christianson | Jan 22, 2023 | Cardiovascular Medication and Disease State Clinical Pearls
It is always controversial to come up with a top 5 list but we went for it. Below we have put together a list of the top 5 landmark trials in hyperlipidemia management. (NOTE: This is part of a bigger project that I am working on with Sarah Zahirudin, PharmD,...
by Eric Christianson | Jan 18, 2023 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
In this article, we break down the most important ketamine clinical pearls. Ketamine (ketamine hydrochloride) is FDA approved for general anesthesia in diagnostic and surgical procedures that do not require skeletal muscle relaxation. It has been used on its own or as...
by Eric Christianson | Jan 15, 2023 | Uncategorized
If you have paid close attention, I did release the 2023 NAPLEX Nuggets edition in late 2022 but there was a naming issue. Long story short, I had to unpublish the book and republish it. This is VERY GOOD NEWS for you as I’m offering an amazing deal as I enjoy...
by Eric Christianson | Jan 11, 2023 | Cardiovascular Medication and Disease State Clinical Pearls
Recently we’ve discussed the differences between clopidogrel and prasugrel as antiplatelet medications. However, there are additional medications included in the P2Y12 inhibitor drug class. Today, we’ll be comparing all of the P2Y12 inhibitors: clopidogrel, prasugrel,...
by Eric Christianson | Jan 8, 2023 | Clinical Guideline Updates For Pharmacists
The ADA has released its 2023 guidelines. There are a significant number of impacts on medication therapy, and in this post I will outline my most important takeaways. I was also recently catching up with my friend and fellow pharmacist, Derek Borkowski who is the...
